UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 11, 2006
MONSANTO COMPANY
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware
(State of Incorporation)
|
|
001-16167
(Commission File Number)
|
|
43-1878297
(IRS Employer Identification No.) |
800 North Lindbergh Boulevard
St. Louis, Missouri 63167
(Address of Principal Executive Offices) (Zip Code)
Registrants telephone number, including area code: (314) 694-1000
Not Applicable
(Former Name or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligations under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13a-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
ITEM 2.02. Results of Operations and Financial Condition.
On October 11, 2006, Monsanto Company issued a press release announcing its fourth quarter and
fiscal year 2006 financial and operating results for the period ended August 31, 2006. This press
release is furnished as Exhibit 99 hereto and incorporated herein by reference.
The press release furnished herewith uses the non-GAAP financial measure of earnings per share
(EPS) on an ongoing basis. Our ongoing EPS financial measure excludes certain after-tax items
that we do not consider part of ongoing operations, which are identified as such in the
reconciliation. We believe that our ongoing EPS financial measure presented with these adjustments
best reflects our ongoing performance and business operations during the periods presented and is
more useful to investors for comparative purposes. In addition, management uses the ongoing EPS
financial measure as a guide in its budgeting and long-range planning processes, and as a guide in
determining incentive compensation. The presentation of EPS on an ongoing basis is intended to
supplement investors understanding of our operating performance. This non-GAAP financial measure
may not be comparable to similar measures used by other companies.
We are furnishing the information contained in this report, including the Exhibit, pursuant to
Item 2.02 Results of Operations and Financial Condition of Form 8-K promulgated by the Securities
and Exchange Commission (SEC). This information shall not be deemed to be filed for the
purposes of Section 18 of the Securities Exchange Act of 1934 (Exchange Act) or otherwise subject
to the liabilities of that section, unless we specifically incorporate it by reference in a
document filed under the Securities Act of 1933 or the Exchange Act. By filing this report on Form
8-K and furnishing this information, we make no admission as to the materiality of any information
in this report, including the Exhibit.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(c) |
|
Exhibits |
|
|
|
The following exhibit is filed herewith: |
|
|
|
Exhibit 99 Press Release, dated October 11, 2006, issued by Monsanto Company |
2